Alessandro Paoli | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Elacestrant in ER+, HER2− Metastatic Breast Cancer with ESR1-Mutated Tumors: Subgroup Analyses from the Phase III EMERALD Trial by Prior Duration of Endocrine Therapy plus CDK4/6 Inhibitor and in Clinical Subgroups	CLINICAL CANCER RESEARCH	2024
Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer	BREAST CANCER RESEARCH AND TREATMENT	2023
Identification of small molecules uncoupling the Notch::Jagged interaction through an integrated high-throughput screening	PLOS ONE	2017
Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies?	DISEASE MARKERS	2017
Notch signaling deregulation in multiple myeloma: A rational molecular target	ONCOTARGET	2015